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The ryanodine receptor mediates intracellular calcium ion release with excitation of nerve
and muscle cells. Ryanodine receptor missense variants cause a number of
myopathologies, such as malignant hyperthermia, and have been linked with various
neuropathologies, including Alzheimer’s disease. We characterized the consequences of
ryanodine receptor variants in vivo. Eight Caenorhabditis elegans strains, with ryanodine
receptor modifications equivalent to human myopathic RYR1 variants, were generated by
genome editing. In humans, these variants are rare and confer sensitivity to the inhalational
anaesthetic halothane when heterozygous. Increased sensitivity to halothane was found in
both homozygous and heterozygous C. elegans. Close analysis revealed distinct subtle
locomotion defects, due to the different single amino acid residue changes, even in the
absence of the external triggering agent. Distinct pre- and postsynaptic consequences of
the variants were characterized through the responses to cholinergic pharmacological
agents. The range of phenotypes reflects the complexity of the regulatory inputs to the
ryanodine receptor and the criticality of the calcium ion channel opening properties, in
different cell types and with age. Ryanodine receptors with these single amino acid residue
changes still function as calcium ion channels, but with altered properties which are likely
to have subtle consequences for human carriers of such variants. The long-term
consequences of subtly altered calcium ion signalling could be cumulative and may be
focussed in the smaller nerve cells rather than the more robust muscle cells. It was
important to assess phenotypes in vivo to properly appreciate consequences for a
whole organism.
Keywords: ryanodine receptor, Caenorhabditis elegans, unc-68, malignant hyperthermia, neuromuscular function,
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The ryanodine receptor (RyR) is a key intracellular calcium ion
channel in the sarcoplasmic reticulum (SR) or endoplasmic
reticulum (ER) of excitable and non-excitable cells (Zissimopoulos
et al., 2006). RyRs mediate Ca2+ release from the SR or ER into the
cytosol upon excitation of muscle or nerve cells, respectively.
Although the three isoforms of RyR are often referred to as
skeletal muscle (RyR1), smooth muscle (RyR2), and brain (RyR3)
(Marks et al., 1989; Takeshima et al., 1989; Nakai et al., 1990;
Ledbetter et al., 1994; Zucchi and Ronca-Testoni, 1997) specific,
they are expressed in other tissues. For example, RyR1 is also found
in the brain, most prominently in Purkinje cells (Zissimopoulos
et al., 2006). RyRs are very large proteins, consisting of four identical
monomers of more than 5,000 amino acid residues (Santulli et al.,
2018). Described as “mushroom-shaped”, most of the RyR sits in
the cytoplasm with a small transmembrane domain forming the
pore. The structure of RyRs has been resolved such that the
conformational change of the protein upon channel opening has
been determined (Efremov et al., 2015; Yan et al., 2015; Zalk et al.,
2015). The large cytoplasmic region is key to integration of various
critical regulatory inputs.
RyR variants have been associated with a number of
pathologies, most notably myopathies, including malignant
hyperthermia (MH) (Robinson et al., 2006), age-related decline
in skeletal muscle function (Boncompagni et al., 2006;
Andersson et al., 2011), and heart arrhythmia (Salvage et al.,
2019). Links have also been made, however, to other pathologies,
such as neurodegenerative disease (Del Prete et al., 2014). MH is
a myopathy typically caused by any one of numerous, typically-
dominant, missense variants in RyR1, where exposure to
inhalational anaesthetics results in a severe, potentially fatal,
reaction due to uncontrolled opening of the Ca2+ channel
(Carpenter et al., 2009). The genetic prevalence of individuals
carrying MH associated variants in the general population is
estimated at one in 1,500 individuals (Shaw and Hopkins, 2019)
but the total frequency of RyR1 missense variants is much higher.
MH susceptibility can be diagnosed through an in vitro
contracture test (IVCT) using skeletal muscle biopsy tissue
(Hopkins et al., 2015). Genetic diagnosis may accompany or be
in place of the IVCT should a known MH causing RyR1 variant
be present in the family. There are 48 RyR1 variants recognised
so far as MH diagnostic by the European MH Group. However,
there are over 2500 different missense RyR1 variants in the
Genome Aggregation Database (gnomAD) (Karczewski
et al., 2019).
MH susceptible (MHS) individuals are generally considered
as having no phenotypic changes without anaesthesia
(Rosenberg et al., 2015). A correlation was once reported,
however, between histopathological appearance and IVCT
response for MHS versus MH negative individuals (Mezin
et al., 1997). Also, skeletal muscle structural abnormalities have
been found in mice with a viable homozygous RyR1 variant
knock-in (Yuen et al., 2012). Furthermore, a number of other
myopathies associated with RyR1 missense variants, such as
Central Core Disease (CCD) and Multiminicore disease
(MmD), manifest as muscle weakness, which can range fromFrontiers in Genetics | www.frontiersin.org 2mild to life threatening (Robinson et al., 2006), and knock-in
mice carrying one of the most common CCD RyR1 variants
(I4895T) demonstrated reduced muscle strength (Loy et al.,
2011). Nevertheless, it is important to fully understand the
consequences of missense RyR1 variants in vivo, in the absence
of a triggering agent, given the frequency of such variants in the
human population and the complexity of this channel’s
regulatory control.
With the complexity of mammalian systems, the nematode
Caenorhabditis elegans provides a more convenient and simpler
experimental system for study of ryanodine receptor function in
vivo. C. elegans has a single gene, unc-68, encoding all the RyR
function in the worm, including for both muscle cells and nerve
cells. The power of genetic manipulation in C. elegans allows for
precise missense modifications in the genome to be generated
and studied with relative ease. Additionally, C. elegans strains
carrying unc-68 modified as per pathological RYR1 variants, in
extrachromosomal arrays, were shown previously to confer MH-
related phenotypes of increased sensitivity to IVCT testing
agents, caffeine, and the inhalational anaesthetic halothane
(Nicoll Baines et al., 2017).
Here, an investigation of C. elegans strains carrying missense
mutations in the chromosomal copy of unc-68, generated using
CRISPR-Cas9 genome editing, is reported. Eight mutations
corresponding to known or suspected myopathic RYR1
variants were studied, all affecting residues conserved from C.
elegans to all three human RyRs. When either homozygous, or
heterozygous with a wild type allele, the variants conferred an
MH-related phenotype of increased anaesthetic sensitivity.
Furthermore, additional phenotypes were seen even in the
absence of a triggering agent. These additional phenotypes
were observed across a range of ages, from the earliest larval
stage to old adults, and were quantified by close analysis of worm
locomotion. Assays using drugs to interrogate function at the
neuro-muscular synapse revealed distinct phenotypes for the
different unc-68 variants, providing insight into the potential
consequences of human RyR1 variants on Ca2+ channel function
in vivo.MATERIALS AND METHODS
Caenorhabditis elegans Culture
All C. elegans strains were maintained at 20°C, on 50 mm plates
of nematode growth medium (NGM) (3 g NaCl, 17 g Agar, 2.5g
Peptone in 975 ml water, autoclaved and cooled to 55°C before
addition of 1 ml 1M CaCl2, 1 ml 1M MgSO4, 1 ml cholesterol (5
mg/ml in ethanol), and 25 ml 1M KPO4 (pH 6)) (Stiernagle,
2006). Plates were seeded with 150 µl of an OP50 Escherichia coli
overnight culture, grown in LB.
C. elegans Strains
C. elegans strains were generated by CRISPR-Cas9 genome
editing. UL4239 (hR163C) (le4239) and UL4285 (hN2342S)
(le4285) were generated at the University of Leeds from an N2
Bristol strain, obtained from the MRC-LMB, Cambridge. Strains
COP1879 (hG341R) (knu765), COP1883 (hR2163H) (knu810),February 2020 | Volume 11 | Article 37
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(knu822), COP1932 (hK3452Q) (knu810), and COP1950
(hR4861H) (knu828) were generated by NemaMetrix, also
through injection of an N2 Bristol strain maintained by
NemaMetrix. Due to the different sources of N2 strains used to
generate the variant strains, both Leeds N2 and NemaMetrix N2
were assayed. As no significant differences were found, and for
simplicity, all references to N2 in this manuscript refer to the N2
strain provided by NemaMetrix due to six of eight RyR1 variant
strains originating from this background. The RyR null strain
CB540 (unc-68(e540)) was obtained from the MRC-LMB,
Cambridge. The unc-119 fluorescent reporter strain OH441
(otls45[unc-119::gfp]) was provided by the Caenorhabditis
Genetics Center.
Heterozygous unc-68 variant/wild type and control individuals
were generated by mating. N2 males were mated with OH441
hermaphrodites to generate heterozygous otls45[unc-119::gfp]/wild
type males, which were then mated with unc-68 variant strains,
CB540 (unc-68(e540)) and N2. Hermaphrodites carrying the unc-
119::gfp marker as a result of cross-fertilization were assayed. No
males were used in phenotyping assays.
Synchronisation and Ageing
Young adult, day 10 adult and larval stage one hermaphrodite C.
elegans were used for phenotyping assays. Larval stage
hermaphrodite C. elegans were isolated by washing a mixed stage
population plate with 1 ml S medium into a microcentrifuge tube.
Worms were allowed to settle by gravity for 1 min before pipetting
10 µl of the supernatant to an 8-well slide. By allowing worms to
settle, older and larger animals settled more quickly, thus allowing
smaller and younger animals to be isolated. L1 animals were
discriminated from older stages by size and morphology.
Young adult animals were procured by bleaching mixed stage
populations containing gravid adults. The worms in M9 buffer
were mixed with 0.3 volumes of a dilute hypochlorite solution, as
in household bleach, and 0.2 volumes of 4M NaOH, until only
eggs remained. Bleaching kills all post-embryonic stages, while
embryos are protected by the egg-shell. Prepared eggs were
transferred to seeded plates and allowed to develop. All
animals hatched within 14 h of each other. 3.5 days after
bleaching, with the presence of a few eggs on the plate,
animals were considered young adults. CB540 (unc-68(e540))
and COP1950 (hR4861H) both took an extra day to reach the
young adult stage, as indicated by the onset of egg laying.
Day 10 animals were generated with synchronisation in the
same way as for young adults. At the L4 stage, 2 days after
synchronisation, animals were washed from 50 mm NGM plates
with M9 to 90 mm NGM plates containing 50 µM FUdR (5-
fluoro-2’-deoxyuridine) (Sigma-Aldrich) and seeded with 450 µl
OP50 E. coli overnight culture. FUdR inhibits DNA synthesis,
preventing fertilised eggs from developing and hatching, while
still allowing adults to lay eggs. There is no somatic cell division
in C. elegans adults. FUdR was only provided when assay animals
are about to mature to avoid developmental abnormalities
associated with FUdR treatment. For this reason CB540 and
COP1950 were only transferred to FUdR plates on day 3 of
adulthood to match the developmental delay. FUdR has beenFrontiers in Genetics | www.frontiersin.org 3found to extend lifespan in certain instances, as well as induce
resistance to stress (Anderson et al., 2016). Here, neither lifespan
or stress resistance were assessed, and so it was deemed
appropriate to use FUdR to limit progeny hatching.
Halothane Sensitivity and Swimming
Assays
Halothane assays were conducted on individuals of the
appropriate age. Well-fed individuals were selected from NGM
plates and transferred to 1 ml of S medium, or S medium
containing 1 mM, 2.5 mM, or 5 mM halothane. S medium
contains 1 litre S Basal (5.85 g NaCl, 1 g K2HPO4, 6 g KH2PO4, 1
ml cholesterol (5 mg/ml in ethanol), H2O to 1 litre and
autoclaved), 10 ml 1 M potassium citrate pH 6, 10 ml trace
metals solution (1 Litre stock: 1.86 g Na2 EDTA, 0.69 g
FeSO4•7H2O, 0.2 g MnCl2•4H2O, 0.29 g ZnSO4•7H2O, 0.025 g
CuSO4•5H2O, H2O to 1 litre, autoclaved and stored in the dark),
3 ml 1 M CaCl2, 3 ml 1 MMgSO4 (Stiernagle, 2006). Body bends
were counted after 1 min of exposure. 25 worms were assayed for
each strain at each concentration, split into two groups assayed
on different days to confirm reproducibility.
Halothane was prepared as a 125 mM stock in DMSO. Just
prior to assaying, 500 µl of S medium was added to a well of a 24-
well plate, followed by 500 µl of S medium with or without
halothane. An individual was immediately transferred into the S
medium using a sterile worm pick. This method was used to
avoid the halothane/DMSO mixture damaging the plastic of the
plate. Immediate onset of the assay is important due to the
volatility of halothane.
L1 Swimming Assays
10 µl of S medium containing C. elegans L1s was pipetted into
each well of an 8-well microscope slide. C. elegans transferred to
the slide were allowed 1 min to acclimate. One L1 animal was
identified per well of the 8-well slide and body bends were
counted for that individual. 32 animals were assayed per strain,
across two different days.
Quantification of Crawling Gait
Animals were grown to the indicated age and kept well fed, on
NGM plates. One unseeded 90 mm 25 ml NGM plate at 20°C
was used for each strain. Plate temperature is important as it
affects the animals’ locomotion. A 1 mm scale was placed on the
NGM surface and a picture captured, to set the scale in post
recording analysis for each plate, as slight differences in plate
volume will affect the scale. 20–30 animals per strain, of the
appropriate age, were then picked to the plate and recorded
crawling freely for 1 min at 25 fps.
Crawling videos were recorded using a multi-worm tracker
system set up by the Cohen group at the University of Leeds.
This system used a Navitar telemetric lens and a Ximea xiQ USB
camera to capture video of worms crawling on an NGM plate, with
illumination by a PolyTec LED red light ring. Videos were recorded
at 25 fps using StreamPix 7 (version 7.2.1). Scales were calculated for
each video using ImageJ software (Schneider et al., 2012), and videos
were analysed subsequently using TierpsyTracker 1.4.0 software
(Javer et al., 2018). Analysis examples, available online (https://February 2020 | Volume 11 | Article 37
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timeseries data directly by reading the “features” files from
TierpsyTracker 1.4.0 in MATLAB. Primary wavelength,
maximum amplitude, midbody crawling frequency, and body
length were extracted, providing a compiled dataset of all worms
in each tracked frame. Frequency values were converted to positive
as dorsal and ventral distinctions were not considered significant.
For each animal tracked up to 1,500 data points were recorded,
resulting in up to 45,000 data points for each parameter.
Cholinergic Pharmacology Assays
Levamisole and aldicarb assays were conducted on young adult
animals. Aldicarb sensitivity assays were conducted as previously
described (Oh et al., 2017; Oh and Kim, 2017). 50 mm NGM
plates containing 1 mM aldicarb, from 100 mM aldicarb (Insight
Biotechnology) in 70% ethanol, were allowed to dry for at least
one day. This concentration of aldicarb induces paralysis after a
convenient length of time, allowing different levels of resistance
to be readily distinguished. Plates were stored at 4°C and used
within 2 weeks of pouring. Plates were allowed to warm to room
temperature overnight before use. Using forceps, a 16 mm
diameter copper ring was dipped into 70% ethanol and passed
through a flame for ~10 seconds. The ring was then placed
immediately onto one side of an aldicarb-containing plate and
held still with forceps until it had cooled, becoming slightly
embedded into the agar plate. A second copper ring was added to
the plate in the same way, allowing two assays to be conducted at
once. Once the agar had cooled, 10 µl of an OP50 E. coli
overnight culture was pipetted to the centre of each ring. The
combination of food and copper ring is used to corral worms and
limit individuals crawling off plates during the assay. 20–30
animals per strain were placed into the ring and observed
every 10 min for the first 2 h and at 30 min intervals for the
following 2 h. Around 80–100 worms per strain were used, across
a minimum of three repeats.
For the levamisole assays, a 2 M stock of levamisole (Sigma)
in M9 buffer was used to prepare solutions of 100 µM, 1 mM, 10
mM, and 100 mM in M9 buffer. 10–15 individuals were picked
into 1 ml of M9, with or without levamisole, in a well of a 24 well
plate. Individuals were observed every 10 min for 2 h and
locomotion behaviours were documented. Movement
behaviours were then categorised and coded for ease
of representation.
Quantification and Statistical Analysis
Statistical parameters are reported in the figures and corresponding
figure legends. None of the data were removed from statistical
analysis as outliers. All statistical analysis was performed in
GraphPad Prism.
Comparisons of thrashing rate and halothane sensitivity
between genotypes in each condition assayed are expressed as
10–90 percentile box and whisker plots. Differences were
identified as ns, not significant, or significant to *P < 0.05 or
**P < 0.005 using one-way ANOVA. Comparisons between
heterozygotes and homozygotes with unc-68 variant, null or
wild type and comparison between homozygotes of the same
genotype at different ages were conducted using Sidak’s multipleFrontiers in Genetics | www.frontiersin.org 4comparison test for comparison of pre-selected pairs.
Comparisons between unc-68 variant strains and wild type or
the unc-68 null mutant were conducted using Tukey’s multiple
comparison test.
Crawling parameters are represented as scatterplots, for two
of the three crawling parameters, with both vertical and
horizontal error bars (standard error) for young adult and old
adult. Error bars which are smaller than the height of the data
point are not drawn. Statistical analysis of differences between
the strains is not presented here due to the large number of
repeats resulting in significance in most comparisons. This type I
error can occur in very large data sets where small differences can
turn out to be statistically significant. However, when the small
differences are considered in the context of the practical
significance, they are not large enough to be considered
meaningful. Kymograms for single individuals were generated
using the Tierpsy Tracker 1.4.0 software and MatLab. Colour
bars are limited from 1 to -1. Strains with more green have wider
bend angles, while strains with deeper reds and blues have more
acute bend angles. Solid black vertical lines represent frames
where the individual worm’s skeleton could not be tracked by
the software.
Survival fractions in aldicarb were displayed as a Kaplan-
Meier survival curve in GraphPad Prism. Individual strain’s
survival curves were compared to wild type (or the unc-68 null
mutant for COP1950 (hR4861H)) using a Gehan-Breslow-
Wilcoxon test.RESULTS
RYR1 Variant Versions of unc-68
Conferred an MH-Related Halothane
Sensitivity Phenotype
Eight RYR1 missense variants associated with skeletal muscle
pathology in the human population, and which affect single
amino acid residues conserved in the C. elegans ryanodine
receptor UNC-68, were selected. Point mutations were
introduced into the genomic copy of unc-68, in the N2 wild
type strain, through CRISPR-Cas9 genome editing such that the
only change to the amino acid sequence of the gene product
corresponded to human RyR1 variants R163C, G341R, R2163H,
N2342S, R2454H, R2458H, K3452Q, and R4861H (Table 1).
Additional modifications were made around the target codon to
prevent further genome editing but these would not change the
ryanodine receptor amino acid sequence (Supplementary
Table 1).
Eggs prepared from populations of each C. elegans strain were
allowed to develop and halothane sensitivity was assessed when
animals reached young adulthood. The rate of locomotion in
liquid was recorded at a range of halothane concentrations. A
progressive decline in rate of thrashing was seen for all strains in
increasing concentrations of halothane, including the wild type
strain N2. However, all unc-68 mutant strains demonstrated a
much slower rate of thrashing in 5 mM halothane compared to
the wild type (Figure 1). For seven of the eight strains expressingFebruary 2020 | Volume 11 | Article 37
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halothane was, in contrast, close to or indistinguishable from that
of the wild type. This increased sensitivity to halothane,
conferred by these single amino acid changes in the ryanodine
receptor, reflects the anaesthetic sensitivity of RYR1-associated
malignant hyperthermia. Increased halothane sensitivity was
seen previously upon expression of missense unc-68 variants,
but from a high-copy number, extrachromosomal location
(Nicoll Baines et al., 2017), rather than the natural genomicFrontiers in Genetics | www.frontiersin.org 5location assayed here. Expression from the endogenous unc-68
location is expected to provide the normal amount of a gene
product rather than the higher amounts potentially produced
from the extrachromosomal location. Differing halothane
sensitivities were conferred by the different ryanodine receptor
variants as revealed with assays of locomotion at lower halothane
concentrations (Supplementary Figure 1). This variation
parallels the varying MH phenotypes for different RYR1
genotypes (Carpenter et al., 2009).
One unc-68 variant, that for RyR1 hR4861H, conferred a
much-reduced thrashing rate even in the absence of halothane.
This variant strain, COP1950, was indistinguishable from the
unc-68(e540) null mutant strain, CB540, in this assay. This single
amino acid change appeared to totally inactivate the
ryanodine receptor.
Aging Increases Sensitivity to Halothane
for the Wild Type but Not for RyR1 Variant
Strains
Links between ageing and RyR1 variants have been made
previously (Boncompagni et al., 2006; Andersson et al., 2011;
Meissner, 2017; Nicoll Baines et al., 2017). Age is also identified
as a factor of relevance to manifestation of RyR1-related
myopathies (Litman et al., 2018). The median lifespan for
wildtype C. elegans is 15 days into adulthood (Gems and
Riddle, 2000), however, strains transgenic for variant unc-68s,
in extrachromosomal arrays, had shorter lifespans than wild type
(Nicoll Baines et al., 2017). Halothane sensitivity was therefore
re-evaluated for the genome edited strains at day 10 of
adulthood, when the worms were considered to be aged, for
comparison to young adults at day 1 of adulthood. Synchronised
animals, grown from prepared eggs, were maintained on NGMFIGURE 1 | Ryanodine receptor (RyR) variants confer a malignant hyperthermia (MH)-related phenotype of hypersensitivity to halothane. Thrashing rate in S
medium, in body bends per minute, for RyR variant strains, labelled by the human variant they correspond to, in the absence of (A) and presence of (B) 5 mM
halothane / 4% DMSO. 25 individual young adults were examined per strain. Boxes indicate the median and interquartile range, with whiskers to the 10–90
percentile, outliers as dots, and + to indicate the mean. Significance is between variant strains and the N2 wild type, apart from where indicated to the CB540 unc-
68(e540) null mutant. *P < 0.05, ** P < 0.005, n.s, not significant (one-way ANOVA, with Tukey’s multiple comparison test). Colouring corresponds to variant location
in the protein. Yellow/orange variants are located within the N-terminal domain (NTD), green in the helical domain (HD), and blue in the transmembrane domain
(TMD). Gray represents wild type and lilac the null mutant.TABLE 1 | Amino acid alignment of human RyR1 and C. elegans UNC-68 in the
regions of the studied variants, and the C. elegans strain expressing the variant
UNC-68.
Human RyR1
variant (C.
elegans variant)
Alignment C. elegans
strain
R163C
(R169C)
RyR1 ASKQRSEGEKVRVGDDIILVS
UL4239UNC-68 ASKQRSEGEKVRVGDDVILVS
G341R
(G350R)
RyR1 PPEIKYGESLCFVQHVASGLW
COP1879UNC-68 NATIRYGETNAFIQHVKTQLW
R2163H
(R2246H)
RyR1 LLECLGQIRSLLIVQMGPQEE
COP1883UNC-68 FLVYLIQIRELLTVQFEHTEE
N2342S
(N2441S)
RyR1 DFLRFAVFVNGESVEENANVV
UL4285UNC-68 DFLRFCVWINGENVEENANLV
R2454H
(R2560H)
RyR1 AGKGEALRIRAILRSLVPLED
COP1947UNC-68 AGKGDSLRARAILRSLISLDD
R2458H
(R2564H)
RyR1 AGKGEALRIRAILRSLVPLED
COP1944UNC-68 AGKGDSLRARAILRSLISLDD
K3452Q
(K3675Q)
RyR1 IYWSKSHNFKREEQNFVVQNE
COP1932UNC-68 RIWSQSQHFKREELNYVAQFE
R4861H
(R5021H)
RyR1 VVVYLYTVVAFNFFRKFY-NK
COP1950UNC-68 VVVYLYTVIAFNFFRKFYVQEThe residue changed in the variants is in bold and underlined. The UNC-68 residue
numbering is based on isoform a.February 2020 | Volume 11 | Article 37
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prevent progeny hatching. This allowed assay of aged animals
without confusion with subsequent generations.
Individuals at day 10 of adulthood were assayed for halothane
sensitivity as before. Thrashing rate for old adults was
approximately half that seen in young adults, in the absence of
halothane, in all strains, reflecting a general reduction of locomotion
as the animals age (Figure 2A). For most of the unc-68 variant
strains, the thrashing rate of old adults in the presence of 5 mM
halothane was not significantly less than that of young adults,
although it was for the wild type (Figure 2B). That the thrashing
rate of aged adults in the presence of halothane was not reduced
further while the thrashing rate in the absence of halothane was,
suggests that in most of the variant strains, with a modified RyR,
halothane is having less of an effect in aged animals than in younger
animals. The halothane could have reduced the thrashing rate of
these old adults further, as seen for the unc-68 null mutant and the
hR4861H unc-68 variant strain, which behaves as a null mutant.
The effect of halothane appears as strong in old adults as in young
adults in the presence of wild type unc-68, although the variant
strains remain less motile in the presence of halothane than the wild
type. Curiously, hK3452Q, the only functional variant for which the
strain showed a significant further reduction of locomotion of old
adult versus young adult in the presence of halothane, corresponds
to that associated with Late Onset Axial Myopathy, a condition that
manifests in older human individuals. However, the effect is small
and this could be just coincidental. Nevertheless, the relative
locomotion of variant strains as compared to the wild type and
the unc-68 null mutant in the presence and absence of halothane for
old adults (Supplementary Figure 2) was very similar to that for
young adults.
RyR Variant Strain L1s Have Reduced
Thrashing Rate
Given the reduced effect of halothane on aged adults as compared
to young adults, in the presence of RyR variants, the effects of
RyR1 variants on larvae was assessed. It was surmised that the
animals might gradually adapt to the presence of a defective RyR
as they age and, if so, the consequences of RyR variants could be
more marked in younger worms. Larval stage one, L1, is the
earliest stage where C. elegans are hatched from the egg and are
freely moving. L1s were collected from mixed stage plates and
frequency of body bends was counted for single individuals.
At the L1 stage, in the absence of halothane, all RyR variants
caused a markedly reduced thrashing rate compared to N2 wild
type (P < 0.005) (Figure 2C). The hR4861H variant caused the
most reduced L1 locomotion, once again matching that of the unc-
68 null mutant. However, the effect on locomotion due to the other
RyR variants was more substantial for L1s than for adults. The
reduction in L1 thrashing rate in liquid in the absence of halothane
was significant for all the variant strains, not just some.
RyR Variant Strain Crawling Is
Distinguishable From Wild Type
To characterize locomotion in the RyR variant C. elegans strains
more closely, crawling on agar was examined. Crawling is a slowerFrontiers in Genetics | www.frontiersin.org 6movement than thrashing, and is restricted to a flat surface, creating
a sinusoidal wave in the animal’s dorsal-ventral plane which can be
more easily measured and quantified. Young adults were videoed
and the maximum amplitude, midbody frequency, primary
wavelength and body length, during crawling, were extracted
(Figure 3, Supplementary Table 2). Computer analysis of the
videos involved 1,500 data points for each individual, and 20 to
30 individuals were analysed per strain, providing robust
quantification of locomotion parameters.
Mean lengths of age synchronised worms varied between the
different strains, suggesting RyR variants affect growth and/or
development of the animals (Figure 3B). The unc-68 null mutant
has delayed development, matching that for the hR4861H
variant strain. However, the other RyR variants also affect
development, but more subtly. Most of the RyR variant strains
had a mean length shorter than wild type, although the strains
for variants hR2163H and hN2342s were slightly longer. Due to
the differences, wavelength, and amplitude of the locomotion
were normalized with respect to worm length.
The maximum amplitude of a worm’s crawling motion is the
distance between the midline and the peaks of the locomotion
sine wave. Once corrected for differences in length, the different
strains had only subtle differences in maximum amplitude. The
mean maximum amplitude for all strains was between 0.16 to
0.19 times the mean length for that strain. The wild type and the
unc-68 null mutant had the largest mean maximum amplitude,
with respect to length, and were found to be indistinct from each
other upon statistical analysis, (P = 0.9991, One-way ANOVA
with Tukey’s test). All of the RyR1 variant strains had smaller
amplitude:length ratios and were significantly different to both
wild type and the null mutant. Of note, is the large difference in
mean maximum amplitude:length ratio seen for the unc-68 null
mutant and the hR4861H variant strain, suggesting that this
variant is not actually a null mutant, as suggested from the liquid
assays, and some functionality remains.
The primary wavelength of the crawling is the direct distance
between the peaks of the sine wave, again assessed with respect to
worm length. Wavelength was found to range from 0.55x to 0.7x
the length of the worm. For this parameter, the hR4861H variant
strain and the unc-68 null mutant were statistically
indistinguishable (P = 0.2341, One-way ANOVA with Tukey’s
test), and these strains had the largest wavelength:length ratios
(0.691x (se = 0.004) and 0.696x (se = 0.003) the length
respectively). The wild type had a larger wavelength:length
ratio than the other variant strains at 0.626x (se = 0.001) the
mean length. Wavelength:length ratio was very similar for most
of the other RyR variant strains ranging from 0.582x to 0.609x
the length of the worm, except for the hR2458H variant strain,
which had a much shorter wavelength (0.553x (se = 0.0005)
the length).
While the differences for amplitude and wavelength, with
respect to worm length, were subtle, when plotted together the
variant strains sit quite separately from the wild type and the
unc-68 null mutant (Figure 3C). All the variant strains have a
shorter amplitude and/or shorter wavelength than the wild type
and unc-68 null mutant. The combination of shorter amplitudeFebruary 2020 | Volume 11 | Article 37
Graham et al. Ryanodine Receptor Variant PhenotypesFIGURE 2 | Locomotion is differentially affected across the lifespan by ryanodine receptor (RyR) variants. Thrashing rate in S medium, in body bends per minute, for
RyR variant strains, labelled by the human variant they correspond to, along with the N2 wild type and the CB540 unc-68(e540) null mutant. Comparisons are
between young adult (YA) and old adult (OA) in the absence (A) and presence (B) of 5 mM halothane or between strains as L1s in the absence of halothane (C). 25
individuals were examined per strain. Boxes indicate the median and interquartile range, with whiskers to the 10–90 percentile, outliers as dots, and + to indicate the
mean. Significance is between ages of each variant strain (A, B) or to the wild type (C). *P < 0.05, **P < 0.005, n.s, not significant [one-way ANOVA, with Sidak’s
multiple comparison test (A, B), and Tukey’s multiple comparison test (C)].Frontiers in Genetics | www.frontiersin.org February 2020 | Volume 11 | Article 377
Graham et al. Ryanodine Receptor Variant Phenotypesand shorter wavelength, as in most of the RyR1 variant strains,
results in a tighter bend angle during crawling.
Midbody crawling frequency, expressed in waves per second,
is a measure of the time it takes for one complete body bend to
propagate from head to tail. All RyR variant strains had a higher
mean crawling frequency than the wild type (0.49 Hz (se = 0.001
Hz) to 0.40 Hz (se = 0.001 Hz) versus 0.35 Hz (se = 0.001 Hz)),
except for that for hR4861H. The mean crawling frequency for
the hR4861H variant (0.29 Hz (se = 0.004 Hz)) was lower than
for the wild type but higher than for the unc-68 null mutant (0.22
Hz (se = 0.003 Hz)). While absence of RyR function reduced
frequency for both thrashing in liquid and crawling on agar,
most of the RyR1-based single amino acid changes increased
crawling frequency. Again, the differences between the strains is
clear when amplitude and frequency are plotted against each
other (Figure 3D).
The crawling parameters provide an insight into the effects of
these single amino acid changes on RyR function in vivo and the
consequences for Ca2+ dynamics. Those effects can be readilyFrontiers in Genetics | www.frontiersin.org 8appreciated from comparison of the kymograms (see later,
Figure 4D) which emphasize the differences in the crawling
behaviour. The higher frequencies than wild type for most of
the RyR variant strains might be expected because their smaller
wavelength and amplitude means their movement is
less pronounced.
Crawling Parameters Reveal Different RyR
Variants Have Distinct Ageing
Consequences
Careful analysis of crawling on agar surfaces revealed locomotion
differences between RyR variant strains in young adults which
were not apparent for thrashing in liquid. Therefore, crawling
parameters were also determined for old adults, at day 10 of
adulthood (Table 2, Figure 4, Supplementary Table 2).
Worm lengths of old adults also exhibited differences between
strains suggesting that RyR variants affect adult growth as well as
earlier development (Figure 4A). The unc-68 null mutant and
the hR4861H variant strain are much shorter than the otherFIGURE 3 | Young adult crawling differences due to ryanodine receptor (RyR) variants. Amplitudes and wavelengths of the crawling wave form (A) were extracted
from 1 min long, 25 frames per second, video recordings of 20–30 individual young adults, along with worm length and wave frequency. Worm length (B), maximum
amplitude versus wavelength (C), and maximum amplitude versus frequency (D) for RyR variant strains, labelled by the human variant they correspond to, along with
the N2 wild type and the CB540 unc-68(e540) null mutant, were compared. Maximum amplitude and wavelength were normalized for worm length. Boxes indicate
the median and interquartile range, with whiskers to the 10–90 percentile, outliers as dots, and + to indicate the mean (B). Mean and SEM are indicated, although
SEM is very small for frequency and for normalized maximum amplitude and wavelength (C, D).February 2020 | Volume 11 | Article 37
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old adult. The body length variation between the other RyR
variant strains, and for the other variant strains compared to the
wild type, was not as marked in the old adults as in the
young adults.
Both the amplitude and wavelength of locomotion, both with
respect to body length, increased in all strains from young to old
adult (Table 2, Figure 4B). The smallest change was for the wild
type, with only a 2% increase in amplitude and 9% increase inFrontiers in Genetics | www.frontiersin.org 9wavelength. The amplitude increase of the unc-68 null mutant
was substantial at 18% but the wavelength increase was even
smaller than the wild type at just 3%. In comparison, for all RyR
variant strains, the amplitude increase with age was larger than
for the wild type ranging from 9% to 33%, and the wavelength
increase was larger than for both the wild type and unc-68 null
mutant at 10 to 32%.
Midbody crawling frequency decreased for all strains with age
(Table 2, Figure 4C), the aged adults moving much more slowly,FIGURE 4 | Effect of ryanodine receptor (RyR) variants on crawling changes with ageing. Crawling amplitudes, wavelengths and frequencies, and worm lengths, were
extracted from 1 min long, 25 frames per second, video recordings of 20–30 individual 10-day old adults. Worm length (A), maximum amplitude versus wavelength (B) and
maximum amplitude versus frequency (C) for RyR variant strains, labelled by the human variant they correspond to, along with the N2 wild type and the CB540 unc-68(e540)
null mutant, were compared. Maximum amplitude and wavelength were normalized for worm length. Boxes indicate the median and interquartile range, with whiskers to the
10–90 percentile, outliers as dots, and + to indicate the mean (A). Mean and SEM are indicated, although SEM is very small for frequency and for normalized maximum
amplitude and wavelength (B, C). The change in maximum amplitude and primary wavelength from young adult (hollow symbols) to old adult (solid symbols), is indicated by a
straight line (B, C). Representative kymograms are presented for the N2 wild type and for hR2163H and hR2458H RyR variant strains for (D) young adults (YA) and (E) old
adults (OA). Colour indicates degree of dorsal/ventral curvature (red/blue high curvature, green no curvature) at different positions along the body axis (0 anterior to 50
posterior) for each frame of the video recording. Individual frames where parameters could not be extracted are black.February 2020 | Volume 11 | Article 37
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mutant. For N2 and variants hR163C, hN2342S, hR2454H and
hK3452Q, crawling frequency remained ≥ 0.23 Hz. For variants
hG341R, hR2163H, hR2458H, and hR4861H and the unc-68 null
mutant, crawling frequency was ≤ 0.22 Hz.
The changes in crawling wavelength, amplitude and
frequency with age, seen for all strains, means that body
bending is shallower and slower in older individuals. These
differences are immediately apparent in the kymograms
(Figures 4D, E). Aged animals do not contract body wall
muscles to the same extent and as quickly as young adults.
This effect of ageing is more dramatic in the RyR variant strains
than in the wild type.
RyR Variants Have Distinct Presynaptic
Effects
RyRs are important for nerve cell, as well as muscle cell, function.
For example, RyRs have been shown to have a specific role in the
release of the neurotransmitter acetylcholine (ACh) at mouse
neuromuscular junctions (NMJs) (Khuzakhmetova et al., 2014).
In C. elegans, UNC-68 has also been shown to have a presynaptic
as well as a postsynaptic role (Liu et al., 2005). The variant amino
acid changes could have effects on RyR function in nerve cells or
muscle cells or both. Therefore, the consequences of RyR
variants, in our genome edited strains, with respect to
cholinergic neurotransmission at C. elegans NMJs were assessed.
Application of aldicarb and levamisole has been used to
distinguish between pre- and post-synaptic effects of C. elegans
mutations (Rand, 2007). Aldicarb is an inhibitor of C. elegans
acetylcholinesterase (AChE) and prevents the breakdown of ACh
to cause a build-up of synaptic ACh, the excitatory transmitter at
NMJs, resulting in hypercontracted paralysis. Mutations
resulting in an excess of neurotransmitter release from the
presynaptic cell result in a more rapid build-up of ACh, and
thus more rapid paralysis, in the presence of aldicarb (Rand,
2007). Conversely mutations disrupting ACh release lead to
aldicarb resistance and slower paralysis. Contributions from
postsynaptic effects have been distinguished using levamisoleFrontiers in Genetics | www.frontiersin.org 10(Lewis et al., 1980). Levamisole is a cholinergic agonist, binding
specifically to levamisole-sensitive nicotinic ACh receptors (L-
nAChRs), present at NMJs. The activation of the postsynaptic
membrane by levamisole results in muscle hypercontraction,
which is typically followed by relaxation and death. Mutations
with postsynaptic effects can modify sensitivity to levamisole.
Assessment of strains for both aldicarb and levamisole resistance
could reveal details of the consequences of the RyR variants for
cholinergic neurotransmission.
The strains for RyR1 variants hR2454H and hK3452Q
responded very similarly to aldicarb and appeared slightly
more sensitive than the N2 wild type (Figure 5). Although all
three strains showed the same median time to paralysis of 80
min, this could reflect a lack of resolution due to sampling
intervals. Analysis of the Kaplan-Meier curves revealed the
difference from N2 was only just statistically significant for the
hK3452Q variant, and not at all for the hR2454H variant. In
contrast, the six other RyR variant strains exhibited resistance to
aldicarb in comparison to N2. The strain for variant hR2163H
had a median time to paralysis of 90 min, while four other
variant strains, hR163C, hG341R, hN2342S, and hR2458H
exhibited further resistance with 100 min median paralysis
times. The strain for the hR4861H variant showed theTABLE 2 | Mean percentage change from young adult to old adult in maximum
amplitude and primary wavelength, both corrected for worm length, and in
midbody frequency.
Strain Maximum Amplitude:
length
Primary Wavelength:
length
Midbody
Frequency
Wild type +2% +9% -33%
hR163C +9% +21% -49%
hG341R +21% +21% -56%
hR2163H +9% +10% -51%
hN2342S +14% +32% -42%
hR2454H +18% +25% -48%
hR2458H +33% +18% -62%
hK3452Q +23% +17% -43%
hR4861H +12% +21% -38%
unc-68
null
+18% +3% -1%Percentages are for ryanodine receptor (RyR) variant strains, listed according to the
human variant they correspond to, along with the N2 wild type and the CB540 unc-68
(e540) null mutant.FIGURE 5 | Ryanodine receptor (RyR) variants alter time to paralysis in 1 mM
aldicarb. Kaplan-Meier survival curves representing the percentage of
individuals still moving with time in 1 mM aldicarb. Data for the RyR variant
strains, labelled by the human variant they correspond to, along with the N2
wild type and the CB540 unc-68(e540) null mutant are distributed across two
graphs for clarity. Comparison to the wild type, and of the hR4861H variant
strain to the unc-68 null mutant (square bracket), to assess if curves were
significantly different, employed the Gehan-Breslow-Wilcoxon test; *P < 0.05,
*P < 0.005, n.s, not significant.February 2020 | Volume 11 | Article 37
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mutant, with both having median paralysis times of 210 min.
Initial levamisole sensitivity assays used a conventional
concentration of 1 mM (Qian et al., 2008). Movement of
individuals from the different strains, in liquid, was noted at 10
min intervals for 2 h (Table 3). In the absence of levamisole,
individuals of each strain remained swimming rapidly
throughout. After an hour, swimming became less smooth for
short intervals, but did continue. The N2 wild type worms all
became straight and paralysed by 1 mM levamisole within 20
min. The unc-68 null mutant and the hG341R, hR2163H, and
hN2342S variant strains responded to levamisole to the same
degree or very similarly to the wild type. The hR2163H mutation
appeared to cause a slight increase in sensitivity, with paralysis by
10 min. The hN2342S mutation appeared to cause a slight
decrease in sensitivity with some individuals showing weak,
occasional twitching, curling, folding, shivering or head
waving, which we refer to as “attenuated movement”, from the
onset of paralysis at 20 min, until complete paralysis of all
individuals after 100 min. The hR4861H mutation caused a
more substantial decrease in levamisole sensitivity, responding
quite differently in this assay from the unc-68 null mutant.
Attenuated movement continued in all hR4861H strain
individuals until 30 min and in some individuals from 60 min
onwards, as if becoming partially refractile to the levamisole.
More strikingly, several RyR variant strains, those for
hR163C, hR2454H, hR2458H, and hK3452Q, exhibited a novel
“kinking” phenotype in 1 mM levamisole (Video available online
at https://www.dropbox.com/s/uout8m64ly3gm1a/17-46-28.000.
avi?dl=0). These worms exhibited intermittent sharp bending in
both directions at kinks between straight and rigid sections, in
varying positions down the anterior/posterior axis. While some
individuals of the hR2454H strain did eventually show complete
paralysis from 100 min, no individuals of the hR163C, hR2458H,
and hK3452Q strains showed complete paralysis across the 2 h of
observation. There was some variation between the variants in
the time of switching to the kinking phenotype from a less
specific locomotion defect, and eventually back again. This
phenotype appeared weakest for hR2454H, with no time point
when all individuals exhibited kinking, and strongest forFrontiers in Genetics | www.frontiersin.org 11hR2458H, with kinking retained by all individuals until the
end of observation.
To explore if the kinking phenotype could be induced in the
other strains, the response to higher and lower concentrations of
levamisole was investigated. This provided further support for
the increased sensitivity of the hR2163H strain as compared to
the wild type, with all individuals rapidly paralysed even at 100
mM levamisole. Also, partial recovery from complete paralysis at
higher levamisole concentrations was observed for several of the
strains, including the wild type, with the shift to and from
complete paralysis becoming earlier with increasing levamisole
concentrations. At 100 mM levamisole, complete paralysis could
be induced eventually in all strains. However, while the kinking
phenotype was seen at higher levamisole concentrations for the
RyR variant strains which had expressed this phenotype in 1 mM
levamisole, the kinking phenotype was never observed for the
wild type, the unc-68 null mutant or any of the other RyR
variant strains.
In liquid, the response of the unc-68 null mutant to levamisole
appears very similar to wild type. The partial levamisole
resistance described previously for unc-68 null mutants on an
agar surface (Lewis et al., 1980), may be attributed to the slower
worm body flexing or greater force requirement, making
intracellular Ca2+ release more critical for muscle contraction
than in worms in liquid. The novel kinking phenotype of four of
the RyR variant strains and the greater levamisole sensitivity of
the hR2163H strain, in liquid, are quite distinct from the
phenotype of the unc-68 null mutant and therefore reflect a
gain of an activity in an aspect of RyR function as a result of the
single amino acid changes. Gain of function phenotypes typically
show dominance over the wild type and malignant hyperthermia
susceptibility is mostly a dominant condition (Monnier
et al., 2002).
RyR Variants Conferred a Locomotion
Defect That Was Dominant to Wild Type
Many RYR-related pathologies, including most instances of MH,
exhibit genetic dominance and the condition is expressed in
heterozygous individuals (Monnier et al., 2002). Therefore,
heterozygotes, with the modified unc-68 alleles over the wildTABLE 3 | Response of ryanodine receptor (RyR) variant strains, identified by the human variant they correspond to, and of the N2 wild type and the CB540 unc-68
(e540) null mutant, to 1 mM levamisole in M9 buffer over 2 h.
Time (min)
0 10 20 30 40 50 60 70 80 90 100 110 120
Wild type 2 3 0 0 0 0 0 0 0 0 0 0 0
hR163C 2/3 3/4 4 4 4 4 4 3/4 3 3 3 3 3
hG341R 1/2 2/3 0 0 0 0 0 0 0 0 0 0 0
hR2163H 2/3 0 0 0 0 0 0 0 0 0 0 0 0
hN2342S 1/2 3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0 0
hR2454H 2 3 3 3 3/4 3/4 3/4 3 3 3 0/3 0/3 0/3
hR2458H 1/2 3 3 4 4 4 4 4 4 4 4 4 4
hK3452Q 1/2 3 3 4 4 4 4 4 4 4 3/4 3/4 3/4
hR4861H 2/3 3 3 3 0 0 0/3 0/3 0/3 0/3 3 3 0/3
unc-68 null 2/3 2/3 0 0 0 0 0 0 0 0 0 0 0February 2020 | Volume 11 | ArticNo movement 0, No movement with attenuated movement 0/3, Swimming 1, Uncoordinated swimming 2, Attenuated movement 3, Kinking 4.le 37
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halothane sensitivity. Homozygous RyR variant strain
hermaphrodites were mated with unc-68 wild type males.
Heterozygous, young adult, cross-progeny hermaphrodites were
distinguished from the self-progeny and transferred individually
into liquid medium with or without halothane.
MH is typically described as asymptomatic without the
application of inhalational anaesthetics (Rosenberg et al.,
2015). However, the heterozygotes for all the RyR variants
had slower locomotion in liquid than the wild type control
even in the absence of halothane (Figure 6, Supplementary
Figure 3). The single amino acid changes in UNC-68
conferred an effect on neuro-muscular function even inFrontiers in Genetics | www.frontiersin.org 12normal conditions and in the presence of wild type versions
of the protein.
The unc-68 null phenotype is considered recessive to wild
type (Maryon et al., 1996). Similarly, here, when heterozygotes
are generated in the same way as for the RyR variant strains, but
from the null mutant, the rate of locomotion in liquid was
indistinguishable from the wild type control and much faster
than the homozygous null (Figure 6). One copy of wild type unc-
68 is sufficient to rescue the null phenotype. In contrast, a wild
type copy of unc-68 did not fully rescue the locomotion defect of
the hR4861H unc-68 variant. Even though the hR4861H variant
strain behaved in liquid like the null mutant when homozygous
(Figure 6), this allele is clearly not a null. The aberrant hR4861HFIGURE 6 | Locomotion effects in heterozygous ryanodine receptor (RyR) variant individuals. Thrashing rate in S medium, in body bends per minute, for 25
individuals, in the absence of (A) and presence of (B) 5 mM halothane. Those expressing RyR variants are identified by the human variant they correspond to, and
were either heterozygous (HET), with the modified unc-68 over a wild type unc-68 introduced by mating, or homozygous (HOM) for the modified unc-68.
Corresponding N2 wild type and unc-68(e540) null mutant individuals were generated and assayed in the same way, in parallel, for direct comparison, although the
wild type “heterozygotes” (“HET”) and “homozygotes” (“HOM”) are fully wild type for unc-68. Boxes indicate the median and interquartile range, with whiskers to the
10–90 percentile, outliers as dots, and + to indicate the mean. Significance is between heterozygotes and homozygotes. *P < 0.05, **P < 0.005, n.s, not significant
(one-way ANOVA, with Sidak’s multiple comparison test).February 2020 | Volume 11 | Article 37
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wild type protein, as is the case in the human condition
associated with this missense RyR1 variant.
Remarkably, with the exception of hR4861H, the heterozygotes
had a stronger locomotion defect than the RyR variant
homozygotes. Some RyR variants which failed to show a
locomotion defect, in the absence of halothane, as homozygotes,
now showed such a defect as heterozygotes. The presence of a wild
type UNC-68 enhances the consequences of expressing a variant
UNC-68 for neuromuscular function.
When exposed to halothane all RyR1 variant heterozygotes
exhibited halothane hypersensitivity compared to the N2 wild
type (Supplementary Figure 3). These results are consistent with
the typically dominant inheritance pattern of RYR1 associated
myopathies like MH. However, the rate of locomotion of the
heterozygotes, in liquid in the presence of halothane, was
indistinguishable from that for the homozygotes for the RyR
variant strains. The presence of the wild type UNC-68 did not
enhance the halothane sensitivity due to the variant UNC-68.DISCUSSION
The consequences recorded previously (Nicoll Baines et al.,
2017) for mutations in the C. elegans RyR gene, equivalent to
human myopathic variations, have now been observed with
mutations in the endogenous chromosomal location instead of
in an extrachromosomal array. These mutations increase
sensitivity to halothane, a reflection of the human condition.
Genome editing of unc-68, rather than using a transgene, means
the modified RyR expression level and distribution reflects that
of the wild type. Normal expression of the modified RyRs has
revealed additional significant phenotypes. Effects of the RyR
mutations were observed even without the external triggering
agent, i.e., in the absence of halothane. These included effects of
age, subtle posture changes while crawling over a support surface
and consequences of the presence of a wild type RyR.
First stage larvae of all the RyR variant strains exhibited a
strongly reduced rate of bending while thrashing in liquid, in
comparison to the wild type. In contrast, a significant reduction
in rate of locomotion in liquid, was small and only observed for
some of the unc-68mutations in young and old adults. C. elegans’
postembryonic development from L1 to young adult, involves
both the nervous system, with five of the eight motor neuron
classes generated at the end of L1, and the muscular system, with
14 of the 95 adult body wall muscles being added (Sulston and
Horvitz, 1977). During the L1 stage, one class of ventral cord
motor neurons undergoes complete synaptic reorganisation in
terms of their synaptic pattern in relation to dorsal and ventral
body wall muscle. With much of the neuromuscular system
undergoing development through and after L1, mutations
affecting Ca2+ levels in these cells may have a larger impact at
this stage, or the simpler neuromuscular system of L1s may make
this stage more sensitive to perturbation in RyR function.
Alternatively, the physiology of the worm could adapt
gradually through the lifespan specifically to the subtle defectsFrontiers in Genetics | www.frontiersin.org 13in RyR function due to the unc-68 mutations, progressively
improving locomotion with age.
In depth analysis of crawling on an agar surface revealed that
all strains expressing RyR variants are phenotypically distinct
from both the wild type and the unc-68 null mutant in this
environment too. Differences in crawling amplitude and
wavelength are small for both young and old adults but
presumably reflect differences in RyR Ca2+ channel properties,
with consequences for Ca2+ dynamics during muscle or nerve
excitation. Such consequences would alter Ca2+ levels achieved
and maintained in different cellular compartments. Examination
of the degree of change reveals the increase in crawling amplitude
and wavelength with age is significantly more marked for the
variant strains than wild type and may reflect reductions in
strength and/or increase in duration of muscle contraction. This
could arise from the different Ca2+ dynamics. However, Ca2+
leakage through RyRs has been suggested to lead to progressive
cellular damage. Blocking “leaky” RyRs in old mice resulted in
decreased reactive oxygen species (ROS) and increased muscle-
specific force and exercise capacity (Andersson et al., 2011). A
self-reinforcing cycle of RyR leakage and mitochondrial ROS
production may lead to age-related muscle dysfunction, as
demonstrated in RYR1 variant knock-in mice where older
variant mice had reduced maximal tension which was
preventable with antioxidant supplementation (Durham et al.,
2008). Some Ca2+ leakage occurs through the wild type RyR.
Increased Ca2+ leakage or flow, due to unc-68 missense
mutations could lead to more damage with age.
The difference in worm length between strains could be due to
RyR variants affecting feeding through disturbing either the
neural control or the muscle contraction of pharyngeal
pumping. Mutations which resulted in reduced pharyngeal
pumping or inefficient pharyngeal pumping were found
previously to lead to shorter worms (Morck and Pilon, 2006).
Links have been made between the pharynx in C. elegans and
cardiac pathology associated with human RYR2 variants (Fischer
et al., 2017).
Thrashing defects due to RyR variants were obvious in the
heterozygotes, with a wild type copy of unc-68, even if not
apparent in the homozygote. Previously, in the absence of the
triggering agent, no effect on locomotion due to RyR variants,
expressed in C. elegans from mixed variant/wild type
extrachromosomal arrays as a model of the heterozygous state,
had been discerned (Nicoll Baines et al., 2017). Presumably,
UNC-68 expression levels are critical for a variant UNC-68 to
cause an obviously altered phenotype upon interaction with the
wild type channel, in unchallenged conditions, and expression
from the endogenous locus provides that.
Although the homozygous hR4861H variant strain behaved
very similarly to the unc-68 null mutant, thrashing of the
heterozygote, in the presence and absence of halothane,
matched that of other variant strains. R4861 lies within the
transmembrane, pore-forming, domain of RyR1 (Yan et al.,
2015), the only example amongst the variants studied here,
and may be the most critical to channel function. RyR is a
tetramer, however, and the hR4861H variant RyR subunit, likeFebruary 2020 | Volume 11 | Article 37
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majority of RyR channels in the heterozygotes. Such
incorporation must be sufficient to interfere with, but not
prevent, functioning of the channel. The operation of the small
proportion of channels in the heterozygotes which would be
composed of only wild type subunits is either insufficient or also
interfered with.
Strikingly, for all variants investigated, apart from hR4861H
which appears to block channel function, the homozygote moves
better in liquid than the heterozygote. This suggests that if all
subunits are distorted in the same way by an amino acid residue
replacement, the channel works more like the wild type, in most
cases, than if it is a mixture of normal and variant subunits. A
possible explanation could involve the amino acid changes
impacting upon the different aspects of RyR function
(Witherspoon and Meilleur, 2016). For example, in a
homozygote, an amino acid change might interfere both with
channel closure and activated Ca2+ flow rate, while in the
heterozygote the presence of wild type channel subunits allows
a better Ca2+ flow rate but the channel still closes slowly. As a
consequence, failure to close the channel promptly results in
even more Ca2+ leakage from the sarcoplasmic reticulum in the
heterozygote than in the homozygote. Pathological RYR variants
in the human population are present at low frequency and so are
almost always heterozygous. Nevertheless, our data suggest
subtle functional alteration should be expected for
heterozygous individuals even in the absence of a trigger.
RyRs function in all cells but are particularly critical in
excitable cells. The C. elegans locomotion phenotypes could be
due to the missense mutations modifying RyR function within
the nervous system, affecting neurotransmitter release onto
muscle cells, and/or within muscle cells, with a more direct
impact on muscle cell contraction.
The altered responses to the AChE inhibitor aldicarb suggests
that RyR variants have presynaptic consequences in C. elegans. RyR
misfunction has been linked to neurodegeneration, including
Alzheimer’s disease (Del Prete et al., 2014), and C. elegans has
been used extensively as an experimental system with which to
investigate the role of amyloid in such neurodegeneration (Griffin
et al., 2017). Six of the variants studied appear to reduce the amount
of neurotransmitter release to cause aldicarb resistance, while the
other two variants, hR2454H and hK3452Q, have slightly the
opposite, if any, effect. In excited nerve cells, RyRs are stimulated
to release Ca2+ from the endoplasmic reticulum (ER) into the
cytosol by calcium-induced calcium release (CICR), increasing the
concentration of Ca2+ in the axoplasm and thus increasing the
release of neurotransmitters (Narita et al., 2000; Khuzakhmetova
et al., 2014). In the RyR variant strains which show resistance to
aldicarb, presumably the Ca2+ level is lower, upon nerve cell
excitation, thus reducing ACh release at the synapse. RyR channel
opening could be delayed or channel closing could be premature,
reducing Ca2+ release from the ER through the RyR. Alternatively,
increased Ca2+ leakage through the channel could reduce Ca2+ levels
in the ER, resulting in less Ca2+ being available for release upon
excitation, and/or lower resting Ca2+ levels in the cytosol limiting
the increase achieved upon excitation. Of course, different variantsFrontiers in Genetics | www.frontiersin.org 14could affect any of these steps, and the opposite considerations
would apply for RyR variants which confer aldicarb sensitivity.
An altered response of a mutant to levamisole, which activates
L-type nicotinic ACh receptors on the postsynaptic muscle cell
membrane, is taken to suggest an effect of the mutation within
muscle cells (Rand, 2007). However, while several RyR variant
strains showed subtle changes in sensitivity to levamisole, the
most striking observation was the strong kinking phenotype for
four variants. The kinking phenotype is reported for mutations
in C. elegans genes of the unc (uncoordinated) class typically
involved in neural function, and has been interpreted as a
confl ict between forward and backward locomotion
commands. Perhaps the disturbance of Ca2+ control due to
these RyR variant results in instability across the nervous
system which manifests as random excitation of inhibitory
motor neurons and consequent temporary relaxation of a few
body wall muscles otherwise contracted due to the levamisole.
Notably, strains for the different RyR variants did not show
consistency of responses across the different assay types. The two
variants that conferred increased aldicarb sensitivity (hR2454H
and hK3452Q) did both confer the kinking phenotype in response
to levamisole and were amongst the set showing the greatest
change in crawling parameters with age. Three of the four
variants which failed to show the levamisole induced kinking
phenotype (hG341R, hR2163H, and hR4861H) did also have an
increased aldicarb resistance and showed little change in crawling
parameters with age. The former and the latter phenotypes may
equate to increased and decreased RyR Ca2+ flow/leakage,
respectively. However, the other three variants (hR163C,
hN2342S, and hR2458H) do not conform to this pattern and are
even distinct from each other. Different consequences of the
various RyR mutations may arise from the distinct ways in
which Ca2+ release from the ER could be affected and/or from
disruption of any of the numerous regulatory inputs into RyR
function (Kushnir et al., 2018). Amino acid changes could even
affect regulation of other proteins by the RyR, as suggested for the
hR163C mutation (Estève et al., 2010). Alternatively, the
inconsistencies between the RyR variants could reflect differences
in physiologies between nerve cell types or between nerve cells and
muscle cells. Nevertheless, this variation echoes the variation in
human conditions associated with RyR missense variants.
Despite the differences, all RyR variants tested in C. elegans
conferred increased sensitivity to halothane, reduced the rate of
body bends in liquid and showed genetic dominance. Most
ryanodinopathies are similarly expressed in heterozygous
individuals, exhibiting genetic dominance (Robinson et al.,
2006). However, the presence of an altered C. elegans
phenotype due to these RyR variants in the absence of an
external trigger may have implications for human carriers of
apparently benign as well as pathogenic RYR variants. Although
most of the missense variants in the three RYR genes in the
human genome are present at low frequency in the human
population there are thousands of different variants affecting
residues conserved between RyR1, RyR2, and RyR3 (Lek et al.,
2016). That conservation suggests that those residues are likely to
be of some functional value. RyRs can clearly tolerate manyFebruary 2020 | Volume 11 | Article 37
Graham et al. Ryanodine Receptor Variant Phenotypesamino acid changes without serious consequences for routine
Ca2+ channel operation, but which may well have more subtle
effects. The large amount of individual variation in the human
population means that comparatively small differences in RyR
function may not be readily detectable. Assessment of RyR
variants within an intact organism, like C. elegans, is important
for a proper understanding of the effects, including cumulative,
long-term consequences of ageing.DATA AVAILABILITY STATEMENT
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